Gervasoni JE, Jr., Taneja C, Chung MA, Cady B. Biologic and clinical significance of lymphadenectomy. The Surgical clinics of North America 2000; 80: 1631-1673.
Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 1994; 12: 2229-2234.
Fisch UP. Cervical Lymphography in Cases of Laryngo-Pharyngeal Carcinoma. The Journal of laryngology and otology 1964; 78: 715-726.
Zita G. [Contribution on cervical lymphoscintigraphy]. Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 1967; 107: 644-654.
Robbins KT, Clayman G, Levine PA et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Archives of otolaryngology--head & neck surgery 2002; 128: 751-758.
Hosal AS, Carrau RL, Johnson JT, Myers EN. Selective neck dissection in the management of the clinically node-negative neck. The Laryngoscope 2000; 110: 2037-2040.
van den Brekel MW, van der Waal I, Meijer CJ et al. The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. The Laryngoscope 1996; 106: 987-991.
Teichgraeber JF, Clairmont AA. The incidence of occult metastases for cancer of the oral tongue and floor of the mouth: treatment rationale. Head & neck surgery 1984; 7: 15-21.
Michailov V, Mlatschkov C. [Evaluation of cervical lymph node scintigraphy]. Radiobiologia, radiotherapia 1969; 10: 769-777.
Dunne AA, Jungclas H, Werner JA. Intraoperative sentinel node biopsy in patients with squamous cell carcinomas of the head and neck-experiences using a well-type NaI detector for gamma ray spectroscopy. Otolaryngologia polska. The Polish otolaryngology 2001; 55: 127-134.
Lapidot T, Sirard C, Vormoor J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645-648.
Akashi K, He X, Chen J et al. Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood 2003; 101: 383-389.
Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends in genetics : TIG 1990; 6: 121-125.
Rooprai HK, McCormick D. Proteases and their inhibitors in human brain tumours: a review. Anticancer research 1997; 17: 4151-4162.
Toth M, Gervasi DC, Fridman R. Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells. Cancer research 1997; 57: 3159-3167.
Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. Journal of the National Cancer Institute 1997; 89: 1260-1270.
Chu YW, Yang PC, Yang SC et al. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. American journal of respiratory cell and molecular biology 1997; 17: 353-360.
Llorens A, Vinyals A, Alia P et al. Metastatic ability of MXT mouse mammary subpopulations correlates with clonal expression and/or membrane-association of gelatinase A. Molecular carcinogenesis 1997; 19: 54-66.
Koop S, Khokha R, Schmidt EE et al. Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer research 1994; 54: 4791-4797.
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nature reviews. Cancer 2002; 2: 563-572.
Hofmann UB, Houben R, Brocker EB, Becker JC. Role of matrix metalloproteinases in melanoma cell invasion. Biochimie 2005; 87: 307-314.
Bjorklund M, Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochimica et biophysica acta 2005; 1755: 37-69.
Ala-aho R, Kahari VM. Collagenases in cancer. Biochimie 2005; 87: 273-286.
Wolf K, Mazo I, Leung H et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. The Journal of cell biology 2003; 160: 267-277.
Wyckoff J, Wang W, Lin EY et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer research 2004; 64: 7022-7029.
Amoh Y, Li L, Yang M et al. Hair follicle-derived blood vessels vascularize tumors in skin and are inhibited by Doxorubicin. Cancer research 2005; 65: 2337-2343.
Wyckoff JB, Jones JG, Condeelis JS, Segall JE. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer research 2000; 60: 2504-2511.
Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nature reviews. Cancer 2003; 3: 921-930.
Tsuji K, Yamauchi K, Yang M et al. Dual-color imaging of nuclear-cytoplasmic dynamics, viability, and proliferation of cancer cells in the portal vein area. Cancer research 2006; 66: 303-306.
Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867.
Jurasz P, Alonso-Escolano D, Radomski MW. Platelet--cancer interactions: mechanisms and pharmacology of tumour cellinduced platelet aggregation. British journal of pharmacology 2004; 143: 819-826.
Hofmann UB, Houben R, Brocker EB, Becker JC. Role of matrix metalloproteinases in melanoma cell invasion. Biochimie 2005; 87: 307-314.
Wylie S, MacDonald IC, Varghese HJ et al. The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells. Clinical & experimental metastasis 1999; 17: 111-117.
